A review on graph neural networks for predicting synergistic drug combinations

Milad Besharatifard,Fatemeh Vafaee
DOI: https://doi.org/10.1007/s10462-023-10669-z
IF: 9.588
2024-02-14
Artificial Intelligence Review
Abstract:Combinational therapies with synergistic effects provide a powerful treatment strategy for tackling complex diseases, particularly malignancies. Discovering these synergistic combinations, often involving various compounds and structures, necessitates exploring a vast array of compound pairings. However, practical constraints such as cost, feasibility, and complexity hinder exhaustive in vivo and in vitro experimentation. In recent years, machine learning methods have made significant inroads in pharmacology. Among these, Graph Neural Networks (GNNs) have gained increasing attention in drug discovery due to their ability to represent complex molecular structures as networks, capture vital structural information, and seamlessly handle diverse data types. This review aims to provide a comprehensive overview of various GNN models developed for predicting effective drug combinations, examining the limitations and strengths of different models, and comparing their predictive performance. Additionally, we discuss the datasets used for drug synergism prediction and the extraction of drug-related information as predictive features. By summarizing the state-of-the-art GNN-driven drug combination prediction, this review aims to offer valuable insights into the promising field of computational pharmacotherapy.
computer science, artificial intelligence
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: in drug combination therapy, how to predict drug combinations with synergistic effects efficiently and accurately. Specifically, the paper focuses on using Graph Neural Networks (GNNs) to predict effective drug combinations to meet the challenges in the treatment of complex diseases (especially cancer). Since there are huge obstacles in cost, feasibility and complexity in experimentally screening all possible drug combinations, it becomes particularly important to develop computational models to identify potential synergistic drug combinations. GNNs show great potential in the field of drug discovery because they can process and interpret complex molecular structure data, such as molecular graphs and biological networks, especially in virtual screening, molecular property prediction, protein - ligand binding prediction and drug re - use, etc. By reviewing the existing literature, the paper evaluates the effectiveness and competitiveness of GNN methods in drug combination prediction and discusses the future development directions in this field.